Suchergebnisse - "PENG SHENGKUN"

PubPharm (20)

1

CTLs heterogeneity and plasticity : implications for cancer immunotherapy

enthalten in: Molecular cancer | 2024

von Peng, S. | Lin, A. | Jiang, A. | +5

2

CTLs heterogeneity and plasticity: implications for cancer immunotherapy

enthalten in: Molecular cancer | 2024

von Peng, S. | Lin, A. | Jiang, A. | +5

3

Immune population determination method and system based on multi-dimensional analysis

enthalten in: Europäisches Patentamt | 2023

von WANG YOUYU | FENG GANG | BAI YIFENG | +3

4

Lung cancer postoperative risk model construction method and system based on image combinatorial pathology

enthalten in: Europäisches Patentamt | 2023

von WANG YOUYU | BAI YIFENG | PENG SHENGKUN | +2

5

ROI focus characteristic-based lung cancer influence evaluation method and system

enthalten in: Europäisches Patentamt | 2023

von WANG YOUYU | BAI YIFENG | PENG SHENGKUN | +2

6

Psychiatric disorders associated with immune checkpoint inhibitors : a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

enthalten in: EClinicalMedicine | 2023

von Zhou, C. | Peng, S. | Lin, A. | +7

7

Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features

enthalten in: Open life sciences | 2023

von Fu, J. | Peng, S.

8

Triple-negative mouse breast cancer initiating cells show high expression of beta1 integrin and increased malignant features

enthalten in: Open life sciences | 2023

von Fu, J. | Peng, S.

9

Case Report : Diagnosis of vertebral alveolar echinococcosis upon next-generation sequencing in a suspected tuberculosis

enthalten in: Frontiers in surgery | 2022

von Song, T. | Peng, S. | Zhou, X. | +2

10

Development of a Nomogram Based on 3D CT Radiomics Signature to Predict the Mutation Status of EGFR Molecular Subtypes in Lung Adenocarcinoma : A Multicenter Study

enthalten in: Frontiers in oncology | 2022

von Zhang, G. | Deng, L. | Zhang, J. | +10